Advisory: Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns

(SAMHSA) The use of non-Food and Drug Administration (FDA)-approved cannabidiol, or CBD, has gained attention in recent years, as CBD is becoming increasingly popular and is being marketed for various health conditions. A poll of American adults aged 18 years and older found that 14 percent reported using CBD products in 2019, and a similar poll conducted in 2020 found that as many as 1 in 3 adults reported using CBD products.

However, non-FDA-approved, commercial CBD products marketed to the public and available over the counter differ significantly in composition from those used in clinical studies, and there is limited evidence to support their safety.

The public should be aware of the misconceptions surrounding CBD products, as well as the potential harms and risks associated with their use.

Read more.